Astellas Pharma Ltd.
Astellas Pharma Inc.Oct 18 2024 today announced that the Medicine s and Healthcare products Regulatory Agency has granted authorization for PADCEV™ in combination with KEYTRUDA® for the first-line treatment of adult patients with unresectable or metastatic urothelial cancer, who are eligible for platinum-containing chemotherapy.
“The foundations of advanced bladder cancer treatment haven’t changed since the 1980s,” said Professor. Thomas Powles, Director of Barts Cancer Institute Biomedical Research Centre , UK and primary investigator on the EV-302 trial, “to see EV-302 move from clinical trial to licensed indication within a year shows the strength of those results and the potential benefit to people with advanced bladder cancer.
Behind the news today is a tremendous amount of hard work and collaboration between the medical community and pharma. It’s testament to what we can achieve together and I look forward to doctors across the UK being able to access this combination of medicines for their patients.
Related StoriesAstellas has already reflected the impact from this result in its financial forecast for the current fiscal year ending March 31, 2025.
Antibody Antibody-Drug Conjugate Bladder Bladder Cancer Cancer Treatment Chemotherapy Cisplatin Clinical Trial Healthcare Medicine
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Troubled cinema chain Cineworld asks High Court to approve restructure plansCine-UK Ltd, Cineworld Cinemas Ltd, Cineworld Cinema Properties Ltd and Cineworld Estates Ltd, which are parts of the UK arm of the world’s second-largest cinema chain, are “presently unprofitable”
Read more »
Northampton Market returns home after £10m faceliftThe historic market has new stalls from Italy, new paving, new lighting and new trees.
Read more »
Andor Technology Ltd.Andor Technology, an Oxford Instruments company, is a global leader in the pioneering and manufacturing of high performance scientific imaging cameras, spectroscopy solutions and microscopy systems...
Read more »
Ossila LtdFounded in 2009 by organic electronics research scientists, Ossila aims to provide the components, equipment, and materials to enable intelligent and efficient scientific research and discovery. Over a decade on, we're proud to supply our products to over 1000 different institutions in over 80 countries globally.
Read more »
Ballynahinch company Glas-Seal (NI) Ltd fined over employee deathGlas-Seal Ltd is being fined £30,000 after pleading guilty to a breach of health and safety legislation.
Read more »
Pushing the limits — Pharma characterization with light scatteringBettersize's upcoming webinar will delve into particle size and zeta potential, showcasing their importance in pharmaceutical development and product quality.
Read more »